SS Innovations International, Inc.

SSII ·Healthcare, Medical Devices
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022
Revenue $42.5M $20.6M $5.9M $1.4M
Cost of Revenue $22.9M $12.2M $5.1M $1.4M
Gross Profit $19.5M $8.5M $725.5K $60.6K
Gross Margin 46.0% 40.9% 12.3% 4.2%
Operating Expenses
Research & Development $3.7M $2.5M $1.1M $987.4K
SG&A Expense $14.8M $10.2M $10.1M $1.9M
Operating Income $-8.2M $-19.0M $-20.3M $-3.0M
Operating Margin -19.3% -91.9% -345.1% -206.0%
Interest Expense $271.6K $317.2K $523.4K $162.0K
Pretax Income $-8.2M $-19.2M $-20.9M $-3.2M
Income Tax Expense $4.0M — — —
Net Income $-12.1M $-19.2M $-20.9M $-3.2M
Net Margin -28.5% -92.7% -355.4% -223.8%
EPS (Basic) $-0.06 $-0.11 $-0.14 $-0.03
EPS (Diluted) $-0.06 $-0.11 $-0.14 $-0.03
Shares Outstanding (Basic) 190.0M 170.8M 144.9M 128.2M
Shares Outstanding (Diluted) 198.7M 181.2M 152.1M 128.2M
Dividends Per Share — — — —